<?xml version="1.0" encoding="UTF-8"?>
<patent-document status="new" lang="EN" ucid="EP-1118617-B1" country="EP" doc-number="1118617" kind="B1" date="20050810"><bibliographic-data><publication-reference fvid="23195184" ucid="EP-1118617-B1" status="new"><document-id status="new" format="original"><country>EP</country><doc-number>1118617</doc-number><kind>B1</kind><date>20050810</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-01200093-A" status="new" is-representative="NO"><document-id format="epo" status="new"><country>EP</country><doc-number>01200093</doc-number><kind>A</kind><date>20010112</date><lang>EN</lang></document-id></application-reference><priority-claims status="new"><priority-claim ucid="IT-MI000066" status="new"><document-id format="original" status="new"><country>IT</country><doc-number>MI000066</doc-number><date>20000120</date></document-id></priority-claim><priority-claim ucid="IT-MI20000066-A" status="new"><document-id format="epo" status="new"><country>IT</country><doc-number>MI20000066</doc-number><kind>A</kind><date>20000120</date></document-id></priority-claim></priority-claims><dates-of-public-availability status="new"><intention-to-grant-date><date>20050201</date></intention-to-grant-date></dates-of-public-availability><term-of-grant /><technical-data status="new"><classifications-ipcr><classification-ipcr status="new">A23L   1/29        20060101AFI20051220RMJP        </classification-ipcr><classification-ipcr status="new">A23L   1/29        20060101CFI20051220RMJP        </classification-ipcr><classification-ipcr status="new">A23L   1/30        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr status="new">A23L   1/30        20060101C I20051008RMEP        </classification-ipcr><classification-ipcr status="new">A23L   3/3463      20060101C I20051008RMEP        </classification-ipcr><classification-ipcr status="new">A23L   3/3562      20060101A I20051008RMEP        </classification-ipcr><classification-ipcr status="new">A61K  31/7028      20060101ALI20051220RMJP        </classification-ipcr><classification-ipcr status="new">A61K  31/7028      20060101CLI20051220RMJP        </classification-ipcr><classification-ipcr status="new">A61P  39/00        20060101CLI20051220RMJP        </classification-ipcr><classification-ipcr status="new">A61P  39/06        20060101ALI20051220RMJP        </classification-ipcr><classification-ipcr status="new">C07H  15/00        20060101C I20051008RMEP        </classification-ipcr><classification-ipcr status="new">C07H  15/18        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr status="new">C09K  15/00        20060101CLI20051220RMJP        </classification-ipcr><classification-ipcr status="new">C09K  15/08        20060101ALI20051220RMJP        </classification-ipcr><classification-ipcr status="new">C12N   5/04        20060101ALI20051220RMJP        </classification-ipcr><classification-ipcr status="new">C12N   5/04        20060101CLI20051220RMJP        </classification-ipcr><classification-ipcr status="new">C12P  19/00        20060101CLI20051220RMJP        </classification-ipcr><classification-ipcr status="new">C12P  19/44        20060101ALI20051220RMJP        </classification-ipcr></classifications-ipcr><classification-ecla status="new"><classification-symbol scheme="EC">A23L1/30B</classification-symbol><classification-symbol scheme="EC">A23L3/3562</classification-symbol><classification-symbol scheme="EC">C07H15/18D</classification-symbol></classification-ecla><invention-title lang="DE" status="new">Verbindungen mit antioxidierender Wirkung, diese enthaltende Zusammensetzungen zur Nahrungsmittelergänzung sowie Verfahren zu deren Herstellung</invention-title><invention-title lang="EN" status="new">Compounds with an antioxidant acitivity, compositions useful as food integrators containing them and process for their preparation</invention-title><invention-title lang="FR" status="new">Composés antioxydants, compositions les contenant utilisables dans le domaine de produits alimentaires et procédé pour leur préparation</invention-title><citations /><figures /></technical-data><parties><applicants><applicant format="epo" status="new"><addressbook><name>GIULIANI SPA</name><address><country>IT</country></address></addressbook></applicant><applicant format="intermediate" status="new"><addressbook><name>GIULIANI S.P.A.</name><address><country /></address></addressbook></applicant></applicants><inventors><inventor format="epo" status="new"><addressbook><name>RODA ALDO</name><address><country>IT</country></address></addressbook></inventor><inventor format="epo" status="new"><addressbook><name>FRIGERIO GIULIANO</name><address><country>IT</country></address></addressbook></inventor><inventor format="epo" status="new"><addressbook><name>MINGHETTI ANACLETO</name><address><country>IT</country></address></addressbook></inventor><inventor format="epo" status="new"><addressbook><name>CRESPI PERELLINO NICOLETTA</name><address><country>IT</country></address></addressbook></inventor><inventor format="epo" status="new"><addressbook><name>DANIELI BRUNO</name><address><country>IT</country></address></addressbook></inventor><inventor format="epo" status="new"><addressbook><name>MARCHIORETTO DANILA INGRID</name><address><country>IT</country></address></addressbook></inventor><inventor format="intermediate" status="new"><addressbook><name>CRESPI PERELLINO , NICOLETTA</name><address><country /></address></addressbook></inventor><inventor format="intermediate" status="new"><addressbook><name>DANIELI , BRUNO</name><address><country /></address></addressbook></inventor><inventor format="intermediate" status="new"><addressbook><name>FRIGERIO , GIULIANO</name><address><country /></address></addressbook></inventor><inventor format="intermediate" status="new"><addressbook><name>MARCHIORETTO , DANILA INGRID</name><address><country /></address></addressbook></inventor><inventor format="intermediate" status="new"><addressbook><name>MINGHETTI , ANACLETO</name><address><country /></address></addressbook></inventor><inventor format="intermediate" status="new"><addressbook><name>RODA , ALDO</name><address><country /></address></addressbook></inventor><inventor format="original" status="new"><addressbook><last-name>CRESPI PERELLINO , NICOLETTA</last-name><address><street>Via Losanna, 6</street><city>20154 Milano</city><country>IT</country></address></addressbook></inventor><inventor format="original" status="new"><addressbook><last-name>DANIELI , BRUNO</last-name><address><street>Via S. Martino 11/C</street><city>20122 Milano</city><country>IT</country></address></addressbook></inventor><inventor format="original" status="new"><addressbook><last-name>FRIGERIO , GIULIANO</last-name><address><street>Via Einaudi 15/G</street><city>20020 Arese ( MIlano )</city><country>IT</country></address></addressbook></inventor><inventor format="original" status="new"><addressbook><last-name>MARCHIORETTO , DANILA INGRID</last-name><address><street>Via fratelli di Dio , 168</street><city>20099 Sesto San Giovanni (Milano)</city><country>IT</country></address></addressbook></inventor><inventor format="original" status="new"><addressbook><last-name>MINGHETTI , ANACLETO</last-name><address><street>Via Sapri 39</street><city>20156 Milano</city><country>IT</country></address></addressbook></inventor><inventor format="original" status="new"><addressbook><last-name>RODA , ALDO</last-name><address><street>Via Saragozza , 18</street><city>40123 Bologna</city><country>IT</country></address></addressbook></inventor></inventors><assignees><assignee format="original" status="new"><addressbook><last-name>GIULIANI S.p.A.</last-name><address><street>Via Palagi, 2</street><city>I-20129 Milano</city><country>IT</country></address></addressbook></assignee></assignees><agents><agent format="original" status="new"><addressbook><last-name>De Gregori, Antonella</last-name><address><street>ING. BARZANO' &amp;amp; ZANARDO MILANO S.p.A. Via Borgonuovo 10</street><city>20121 Milano</city><country>IT</country></address></addressbook></agent></agents></parties><international-convention-data><designated-states><ep-contracting-states><country>AT</country><country>BE</country><country>CH</country><country>CY</country><country>DE</country><country>DK</country><country>ES</country><country>FI</country><country>FR</country><country>GB</country><country>GR</country><country>IE</country><country>IT</country><country>LI</country><country>LU</country><country>MC</country><country>NL</country><country>PT</country><country>SE</country><country>TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><abstract lang="EN" source="EPO" status="new"><p>The present invention relates to the use of a compound having general formula (I) as described hereunder &lt;CHEM&gt; wherein R = H (FPA compound) or R = CH3 (FPB compound) for the preparation of compositions with an antioxidant activity for administering to human beings for therapeutic or nutritional purposes. The invention also relates to a process for the preparation of a compound having general formula (I) as defined above characterized in that a cellular culture is obtained from an Ajuga reptans plant, said culture being subsequently subjected to cultivation under aerobic conditions, in a liquid medium containing assimilable carbon and nitrogen sources, and mineral salts.</p></abstract><abstract lang="EN" status="new"><p num="">The present invention relates to the use of a compound
having general formula (I) as described hereunder
<img file="80000001.tif" id="img-EP-1118630-A2-80000001" he="59" wi="90" img-format="tif" img-content="cf" orientation="unknown" inline="no" />
wherein R = H (FPA compound) or R = CH<sub>3</sub> (FPB compound)
for the preparation of compositions with an antioxidant
activity for administering to human beings for therapeutic
or nutritional purposes.</p><p num="">The invention also relates to a process for the preparation
of a compound having general formula (I) as defined
above characterized in that a cellular culture is obtained
from an Ajuga reptans plant, said culture being
subsequently subjected to cultivation under aerobic conditions,
in a liquid medium containing assimilable carbon
and nitrogen sources, and mineral salts.</p></abstract><description lang="EN" status="new"><p num="0001">The present invention relates to compounds having
the formula
<img file="00010001.tif" id="img-EP-1120309-B1-00010001" he="63" wi="91" img-format="tif" img-content="cf" orientation="unknown" inline="no" />
wherein R can be H or CH<sub>3</sub>.</p><p num="0002">Hereinafter in the present description, compound (I)
wherein R = H is called FPA.</p><p num="0003">Compound (I) wherein R = CH<sub>3</sub>, is called FPB.</p><p num="0004">FPA (phenylpropanoid glucoside) has been previously
described and called teupolioside (<ref typ="npl">Chem. Nat. Compd.
1991, 27:5 556-559</ref>), as secondary metabolite, having an 
antimicrobial activity, present in the plant <i>Teucrium
polium</i>. The presence of FPA however has never been described
in other different plants or in &quot;in vitro&quot; cell
cultures of any plant. The preparation of compositions with &quot;FPA&quot;
is known from <ref typ="npl">Chem. Abs. 117: 167262 (1991)</ref>. <ref typ="patent">EP-A-0471 081</ref> discloses an antioxidant having a substitution pattern on the central glucose moiety typical of FPA.</p><p num="0005">FPB, on the other hand, is a compound which has
never been described in literature and as such is therefore
an object of the present invention. According to a
first aspect of the present invention, a production process
of FPA and FPB compounds (jointly called FPs, or raw
FPs), is proposed.</p><p num="0006">This consists in cultivating cells of a cellular
line taken from a plant of <i>Ajuga reptans</i>. For this vegetable
species, bibliographical reference can be made to
<ref typ="npl">Cantino-Sanders, Syst. Bot. Vol. 11 (1986), pages 163-185.</ref></p><p num="0007">According to the invention, parts of this plant
(leaves, shoots and roots) are sterilized by means of sequential
washings with ethanol at 70% for 5 minutes, sodium
hypochlorite at 2% for two minutes and mercuric
chloride at 0.2% for 45 seconds. After each washing with
the sterilizing agents, the parts treated are rinsed with
sterile distilled water.</p><p num="0008">The leaves, shoots and roots are cut into portions,
sterilely planted in Gamborg B5 medium [<ref typ="npl">O.L. Gamborg et
al. Exp. Cell. Res. 50, (1968), page 151</ref>] containing 1 
mg/L of naphthalene-acetic acid, 1 mg/L of kinetin, 0.2
g/L of 2,4-dichlorophenoxyacetic acid (G5 medium) and 7
g/L of agar and are kept in the dark at 28°C.</p><p num="0009">After 10-15 days an undifferentiated tissue (callus)
develops which, after a further 20-30 days, is transferred
onto agarized slants of the same medium. 20 days
at 28°C in the dark are normally required for obtaining
well grown cultures. After 2 or 3 transfers, stabilized
cultures are obtained which are used as inoculum for cultures
in suspension.</p><p num="0010">The cultures grown on solid medium (undifferentiated
callus cultures) consist of small masses of colourless
and easily disaggregable cells. The elliptic-spherical
shaped cells have a diameter of 50-100 µm. Under the
above conditions, the calluses undergoing cultivation do
not show any signs of organogenesis or any differentiation
process. When exposed to light with an intensity
equal to at least 2000 lux, the calluses become green due
to the biosynthesis of the chlorophyll. Exposure to
light, however, does not influence the biosynthesis of
the phenylpropanoids.</p><p num="0011">When cultivated in liquid mediums, the undifferentiated
callus cultures of Ajuga reptans grow in small aggregrates
made up of 5-50 cells. The cells have the same
shape and size as those grown on solid mediums. </p><p num="0012">About 1-2 grams of callus (fresh weight) can therefore
be transferred to a 300 ml Erlenmeyer flask containing
50 ml of liquid G5 medium. After 28 days of incubation
at 28°C in the dark on a trolley with orbital stirring
rotating at 120 revs/minute, the dry weight of the
culture is about 15 mg/mL, and 5 mL of vegetative culture
are inoculated into Erlenmeyer flasks each containing 50
mL of liquid G5 medium. These cultures are incubated at
23°C in the dark on a trolley with orbital stirring at
120 revs/minute for 10-14 days.</p><p num="0013">According to the process of the present invention,
the cells are cultivated in a liquid medium. Flasks or
fermenters made of glass or other materials generally
used, such as, for example, stainless steel, can be
adopted. The liquid medium can be a nutritive solution
containing an assimilable carbon source, an assimilable
source of organic or inorganic nitrogen, inorganic salts
and, optionally vegetable hormones and/or vitamins. The
assimilable carbon source may consist of carbohydrates
such as sucrose, fructose, glucose, starch, dextrin,
glycerol, mannitol and mannose.</p><p num="0014">The assimilable source of organic or inorganic nitrogen
can consist of aminoacids or their mixtures, peptides
or proteins or their hydrolyzate, casein hydrolyzate,
a hydrosoluble fraction of cereals such as the distillation 
residue of maize or wheat in the production of
alcohol, or yeast and also inorganic nitrates and inorganic
ammonium salts.</p><p num="0015">The process of the invention is typically carried
out in a culture in suspension, for example in a flask
under stirring or in an aerated fermenter with a pH ranging
from 5 to 7, preferably 6.5 and at temperatures ranging
from 18 to 36°C, preferably 23°C.</p><p num="0016">The best culture conditions are generally in the
dark at a pH of 5.5 to 6.5 and at temperatures ranging
from 18 to 32°C, for a duration of 8 to 16 days. The production
of raw FPs begins after 2-3 days of growth and
reaches its maximum after 10-14 days.</p><p num="0017">The extraction of the raw FPs can be effected starting
either from cells or from the culture medium or from
the culture <i>in toto.</i></p><p num="0018">The raw FPs are extracted from the filtered cells or
from the culture in toto with a solvent miscible with water,
such as methanol, ethanol or acetone. The raw FPs
are extracted from the culture medium separated from the
cells, by means of extraction in solid phase.</p><p num="0019">The purpose of the following examples is to illustrate
the invention, without limiting its scope.</p><heading><u style="single">EXAMPLE 1</u></heading><p num="0020">The process is carried out in 300 mL Erlenmeyer 
flasks containing 50 mL of G5 medium whose pH is brought
to 6.5 with diluted KOH. The flasks were stirred in a rotating
stirrer at 120 revs/minute with an eccentric of 4
cm. The optimum incubation temperature was 28°C. The
flasks were inoculated with cells of a cellular line of
Ajuga reptans, abbreviated CM75, 14 days old, grown on
solid G5 medium. After 7 days, 5 mL of the cultures were
sterilely transferred to flasks containing 50 ml of the
same medium. After a further 14 days, the production of
raw FPs determined in HPLC, was 2.2 g/L.</p><p num="0021">An equal volume of methanol was added to 5 L of cell
cultures in suspension obtained from 100 flasks, which
were then homogenized and centrifuged.</p><p num="0022">The sediment was resuspended in 1 L of water and 2 L
of methanol and re-extracted twice. The supernatants were
joined and concentrated at reduced pressure to 5 L, and
the aqueous suspension was passed on an XAD resin column.
After washing with 3 L of water and 2 L of methanol at
20%, the material adsorbed was eluted with 3 L of methanol.</p><p num="0023">The organic solvent containing 10.8 g of raw FPs,
determined by HPLC, was evaporated at reduced pressure.
The residue was diluted with water and charged onto a
column in inverse phase of C<sub>18</sub> resin.</p><p num="0024">Elution with acetonitrile at 10% in water gave 7.1 g 
of FPA and further elution with acetonitrile at 20% gave
2.2 g of FPB, both determined in HPLC. The organic solvent
was evaporated at reduced pressure and the aqueous
residues of both products were lyophilized giving 7.9 g
of FPA and 2.5 g of FPB.</p><p num="0025">The phenylpropanoid FPA was finally purified by
means of chromatography on an RP18 Lobar pre-packed column,
eluted with water and increasing quantities of ethanol.
The fractions containing pure FPA were joined and
lyophilized giving 6.6 g of pure FPA with a titer of over
98%. The phenylpropanoid FPB was purified analogously
giving a yield of 1.9 g of pure product with a titer of
over 98%.</p><heading><u style="single">EXAMPLE 2</u></heading><p num="0026">10 g of undifferentiated callus of Ajuga reptans
grown on solid G5 medium were inoculated into a 2 L flask
containing 50 mL of liquid G5 medium. The flask was incubated
in an orbital stirrer at 120 revs/minute at a temperature
of 28°C. After 7 days, the whole culture was inoculated
into a 10 L fermenter containing 6 L of the same
medium sterilized at 120°C for 30 minutes.</p><p num="0027">The culture in suspension was left to grow for 10
days at 20°C under stirring at 100 revs/minute and aerated
with a stream of air of 0.7 L/L of medium/minute.
When the growth had reached a dry weight of about 15 g/L, 
the culture was collected and extracted as described in
example 1.</p><p num="0028">The yield to FPA corresponded to 1.15 g/L of culture
and to 0.36 g/L of FPB.</p><p num="0029">With respect to the process of the invention, it can
generally be seen that the high production yield, the
simplicity of the process, which can be effected in normal
industrial fermenters, and the fact that structures
of phenylpropanoids A and B are almost exclusively produced,
form the main advantages of the present invention.</p><p num="0030">An additional aspect of the present invention consists
in the identification of an antioxidant activity
for FPA and FPB compounds.</p><p num="0031">In particular, the antioxidant activity of FPA and
FPB compounds extracted from <i>Ajuga reptans</i> according to
the process defined above, was tested.</p><p num="0032">The antioxidant capacity &quot;in vitro&quot; of FPA and FPB
compounds, extracted from <i>Ajuga reptans</i>, and &quot;in vivo&quot; of
the serum of rats treated with these substances, was
evaluated by means of a chemiluminescent method and compared
with that of an analogous hydrosoluble product of
vitamin E.</p><p num="0033">The chemiluminescent reaction of luminol was used,
which is oxidized by hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), generating
unstable radicals which degenerate to their basic state 
emitting light. This reaction is catalyzed by peroxidase
enzyme. A signal potentiator is also present in the system:
p-iodophenol which increases the light emission,
producing in turn radicals which degenerate emitting photons.</p><p num="0034">The presence of substances with an antioxidant activity
interrupts the chain of radicalic reactions, temporarily
preventing light emission. The time and extinguishing
degree of the emission of photons are in relation
to the antioxidant capacity and concentration of the
substances being tested.</p><heading><u style="single">Reagents</u></heading><p num="0035"><sl><li>ECL reagent (luminol/H<sub>2</sub>O<sub>2</sub>/p-iodophenol) of Amersham International
(Amersham, UK).</li><li>Radish peroxidase (type VI-A, 1100 U/mg) of Sigma (St.
Louis, MO, U.S.A.).</li><li>Trolox: (+/-)-6-hydroxy-2,5,7,8-tetramethylchroman-2-car-bonsaeure
Sigma (St. Louis, MO, U.S.A.).</li></sl></p><heading><u style="single">Samples</u></heading><p num="0036">Samples relating to FPA and FPB molecules extracted
from <i>Ajuga reptans</i>, were prepared in aqueous solution at
different concentrations (5.0, 2.0, 1.0 and 0.5 µM) and
compared with solutions, at equal concentrations, of
Trolox, an analogous hydrosoluble product of tocopherol.
The serum of rats treated with raw extract of <i>Ajuga rep</i><i>tans</i> by intravenous administration at a dosage of 200
mg/kg were diluted 1:20 with water and compared with the
serum of a non-treated rat.</p><p num="0037">Distilled water was used as control.</p><heading><u style="single">Evaluation of the antioxidant capacity</u></heading><p num="0038">The dosage was effected in black polystyrene cylinders
(Dynatech Laboratories, Chantilly, VA, U.S.A.). The
chemiluminescent mixture was prepared by adding 100 µl of
a dilution 1:10,000 v/v (0.11 U/ml) of a stock solution
of peroxidase (1 mg/ml in a Tris-HCl 0.1 M buffer, pH
8.6) to 5 ml of ECL reagent. The various dilutions of the
samples were distributed in quadruple into the cylinders
(50 µl/cylinder) and 100 µl of chemiluminescent mixture
were added to each. The light emission was measured immediately
using a Luminograph LB980 (EG&amp;G Berthold, Bad
Wildbad, Germany) and the chemiluminescent reaction kinetics
was monitored for about 60 minutes. The light
emission was measured in photons/sec/pixel and the data
obtained are indicated in Table 1 and the graph of Figure
1 enclosed, compared with the control (water) and references
(Trolox or serum of a non-treated rat). <tables><table><tgroup cols="5"><tbody><row><entry align="center">Time</entry><entry align="center">ECL</entry><entry align="center">Trolox</entry><entry align="center">FPA</entry><entry align="center">FPB</entry></row><row><entry align="center">0</entry><entry align="center">31.8</entry><entry align="center">31.8</entry><entry align="center">31.8</entry><entry align="center">31.8</entry></row><row><entry align="center">2</entry><entry align="center">31.8</entry><entry align="center">2.9</entry><entry align="center">1.3</entry><entry align="center">0.3</entry></row><row><entry align="center">5</entry><entry align="center">44.5</entry><entry align="center">7.8</entry><entry align="center">1.4</entry><entry align="center">0.2</entry></row><row><entry align="center">7</entry><entry align="center">48</entry><entry align="center">35.5</entry><entry align="center">1</entry><entry align="center">0</entry></row><row><entry align="center">9</entry><entry align="center">46.7</entry><entry align="center">46.9</entry><entry align="center">0.9</entry><entry align="center">0</entry></row><row><entry align="center">11</entry><entry align="center">45.8</entry><entry align="center">49.3</entry><entry align="center">0.8</entry><entry align="center">0</entry></row><row><entry align="center">14</entry><entry align="center">45.5</entry><entry align="center">50.4</entry><entry align="center">0.8</entry><entry align="center">0</entry></row><row><entry align="center">17</entry><entry align="center">44.1</entry><entry align="center">49.7</entry><entry align="center">0.7</entry><entry align="center">0</entry></row><row><entry align="center">19</entry><entry align="center">43.1</entry><entry align="center">49.2</entry><entry align="center">0.6</entry><entry align="center">0.1</entry></row><row><entry align="center">21</entry><entry align="center">41.9</entry><entry align="center">48.3</entry><entry align="center">0.6</entry><entry align="center">0.4</entry></row><row><entry align="center">23</entry><entry align="center">40.8</entry><entry align="center">47.3</entry><entry align="center">0.6</entry><entry align="center">1.1</entry></row><row><entry align="center">26</entry><entry align="center">38.9</entry><entry align="center">46.2</entry><entry align="center">0.5</entry><entry align="center">1.8</entry></row><row><entry align="center">28</entry><entry align="center">37.8</entry><entry align="center">45.1</entry><entry align="center">0.6</entry><entry align="center">2.6</entry></row><row><entry align="center">30</entry><entry align="center">36.5</entry><entry align="center">43.7</entry><entry align="center">0.5</entry><entry align="center">3.5</entry></row><row><entry align="center">32</entry><entry align="center">34.1</entry><entry align="center">42.1</entry><entry align="center">0.6</entry><entry align="center">5.1</entry></row><row><entry align="center">34</entry><entry align="center">31.5</entry><entry align="center">40.8</entry><entry align="center">1.1</entry><entry align="center">7</entry></row><row><entry align="center">37</entry><entry align="center">29.6</entry><entry align="center">39.3</entry><entry align="center">0.8</entry><entry align="center">6.6</entry></row><row><entry align="center">41</entry><entry align="center">26.7</entry><entry align="center">35.3</entry><entry align="center">0.7</entry><entry align="center">7.6</entry></row><row><entry align="center">44</entry><entry align="center">25.9</entry><entry align="center">35</entry><entry align="center">0.9</entry><entry align="center">8.6</entry></row><row><entry align="center">46</entry><entry align="center">25.1</entry><entry align="center">32.8</entry><entry align="center">0.8</entry><entry align="center">8.9</entry></row><row><entry align="center">49</entry><entry align="center">26.8</entry><entry align="center">31.1</entry><entry align="center">0.8</entry><entry align="center">9.6</entry></row><row><entry align="center">51</entry><entry align="center">26.1</entry><entry align="center">29.6</entry><entry align="center">0.8</entry><entry align="center">10.3</entry></row><row><entry align="center">53</entry><entry align="center">24.9</entry><entry align="center">28.6</entry><entry align="center">0.8</entry><entry align="center">10.9</entry></row><row><entry align="center">56</entry><entry align="center">23.8</entry><entry align="center">26.2</entry><entry align="center">1.1</entry><entry align="center">11.4</entry></row><row><entry align="center">58</entry><entry align="center">20.7</entry><entry align="center">26.8</entry><entry align="center">0.8</entry><entry align="center">12.1</entry></row><row><entry align="center">61</entry><entry align="center">21.9</entry><entry align="center">23.9</entry><entry align="center">1.1</entry><entry align="center">12.7</entry></row></tbody></tgroup></table></tables></p><p num="0039">The FPA and FPB samples proved to have an extremely
high antioxidant activity in vitro, significantly higher
than that of Trolox. The extinguishing time of the light
emission with the same concentration is, in fact, much
higher, as can be seen from the enclosed graph which indicates 
the chemiluminescent test kinetics. It can also
be observed that the FPA compound has a slightly higher
activity with respect to the FPB compound. Table A below
shows the antioxidant activity of the compounds under examination
and of Trolox, expressed as time in minutes
necessary for obtaining a photon emission equal to 50% of
the water control.
<tables><table><tgroup cols="4"><tbody><row><entry namest="1" nameend="4">Time (min.) necessary for reaching 50% of the control light emission</entry></row><row><entry align="center">Concentration</entry><entry align="center">Trolox</entry><entry align="center">FPA</entry><entry align="center">FPB</entry></row><row><entry align="center">5µM</entry><entry align="center">15</entry><entry align="center">&gt;60</entry><entry align="center">&gt;60</entry></row><row><entry align="center">2µM</entry><entry align="center">6</entry><entry align="center">&gt;60</entry><entry align="center">&gt;60</entry></row><row><entry align="center">1µM</entry><entry align="center">3</entry><entry align="center">35</entry><entry align="center">29</entry></row><row><entry align="center">0.5µM</entry><entry align="center">1</entry><entry align="center">13</entry><entry align="center">6</entry></row></tbody></tgroup></table></tables></p><p num="0040">It can be observed for example that with a dosage of
1 µM the FPA activity is almost 12 times higher than that
of Trolox.</p><p num="0041">The antioxidant activity &quot;in vivo&quot; was evaluated by
the intravenous administration of a raw extract of Ajuga
reptans at a dosage of 200 mg/kg. The serum of rats
treated showed a higher antioxidant activity with respect
to the serum of control rats, as can be observed from the
following Table 2, and from the corresponding graph of
Figure 2 enclosed. <tables><table><tgroup cols="4"><tbody><row><entry align="center">Time</entry><entry align="center">Treated 1</entry><entry align="center">Treated 2</entry><entry align="center">Control serum</entry></row><row><entry align="center">0</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">0</entry></row><row><entry align="center">6</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">0</entry></row><row><entry align="center">8</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">1</entry></row><row><entry align="center">10</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">1</entry></row><row><entry align="center">13</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">1</entry></row><row><entry align="center">19</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">26</entry></row><row><entry align="center">24</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">65</entry></row><row><entry align="center">26</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">73</entry></row><row><entry align="center">28</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">76</entry></row><row><entry align="center">30</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">76</entry></row><row><entry align="center">32</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">74</entry></row><row><entry align="center">35</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">72</entry></row><row><entry align="center">37</entry><entry align="center">0</entry><entry align="center">0</entry><entry align="center">69</entry></row><row><entry align="center">45</entry><entry align="center">5</entry><entry align="center">0</entry><entry align="center">68</entry></row><row><entry align="center">47</entry><entry align="center">11</entry><entry align="center">0</entry><entry align="center">67</entry></row><row><entry align="center">49</entry><entry align="center">20</entry><entry align="center">1</entry><entry align="center">65</entry></row><row><entry align="center">51</entry><entry align="center">33</entry><entry align="center">1</entry><entry align="center">63</entry></row><row><entry align="center">54</entry><entry align="center">43</entry><entry align="center">9</entry><entry align="center">63</entry></row><row><entry align="center">56</entry><entry align="center">60</entry><entry align="center">18</entry><entry align="center">62</entry></row><row><entry align="center">58</entry><entry align="center">62</entry><entry align="center">28</entry><entry align="center">61</entry></row><row><entry align="center">60</entry><entry align="center">64</entry><entry align="center">35</entry><entry align="center">60</entry></row><row><entry align="center">62</entry><entry align="center">66</entry><entry align="center">43</entry><entry align="center">58</entry></row><row><entry align="center">64</entry><entry align="center">67</entry><entry align="center">44</entry><entry align="center">57</entry></row><row><entry align="center">67</entry><entry align="center">68</entry><entry align="center">45</entry><entry align="center">57</entry></row><row><entry align="center">70</entry><entry align="center">67</entry><entry align="center">46</entry><entry align="center">56</entry></row><row><entry align="center">78</entry><entry align="center">66</entry><entry align="center">49</entry><entry align="center">55</entry></row><row><entry align="center">81</entry><entry align="center">65</entry><entry align="center">49</entry><entry align="center">54</entry></row></tbody></tgroup></table></tables></p><p num="0042">In conclusion, these derivatives, and in particular
FPA, have proved to have a surprising antioxidant activity
both in vitro and in vivo, much higher than that of
the strongest known antioxidants (vitamin E) and in particular
preferentially directed towards the radicalic 
species of oxygen.</p><p num="0043">On the basis of the experimental indications specified
above, an object of the present invention therefore
relates to the use of FPA and FPB in the preparation of
pharmaceutical, or nutritional compositions, or compositions
which can be used as food integrators, for administering
to human beings, in which an antioxidant activity
is required.</p></description><claims lang="DE" status="new"><claim num="xx"><claim-text>Verwendung einer Verbindung mit der allgemeinen Formel (I)

worin R = H (Verbindung FPA) oder R = CH3 (Verbindung FPB) bedeutet, bei der
Herstellung von Zusammensetzungen mit antioxidierender Wirkung zur Verabreichung
an Menschen zu therapeutischen Zwecken.</claim-text></claim><claim num="xx"><claim-text>Verbindung (FPB) mit der Formel (I), worin R = CH3 ist.</claim-text></claim><claim num="xx"><claim-text>Zubereitung, die als Nahrungsmittelverbinder geeignet sind, enthaltend als aktiven
Bestandteil eine Verbindung mit der allgemeinen Formel (I), wie sie oben definiert
ist, worin R = CH3 ist (Verbindung FPB).</claim-text></claim><claim num="xx"><claim-text>Pharmazeutische Zusammensetzungen, enthaltend als aktiven Bestandteil eine Verbindung
mit der allgemeinen Formel (I), wie sie oben definiert ist.</claim-text></claim><claim num="xx"><claim-text>Verfahren zur Herstellung einer Verbindung mit der allgemeinen Formel (I), wie
oben definiert, dadurch gekennzeichnet, dass man eine Zellkultur aus einer Pflanze
von Ajuga reptans erhält, wobei die Kultur anschließend der Kultivierung unter aeroben
Bedingungen in einem flüssigen Medium unterworfen wird, das assimilierbare
Kohlenstoff- und Stickstoffquellen sowie M: neralsalze enthält.</claim-text></claim><claim num="xx"><claim-text>Verfahren nach Anspruch 5, dadurch gekennzeichnet, dass die Kultivierung unter
aeroben Bedingungen bei einem pH-Wert im Bereich von 5 bis 7, bei einer Temperatur
im Bereich von 18 bis 32 °C und einer zwischen 8 bis 20 Tagen schwankenden
Zeitspanne erfolgt.</claim-text></claim><claim num="xx"><claim-text>Verwendung einer Verbindung mit der allgemeinen Formel (I)

worin R = CH3 ist (Verbindung FPB), zur Herstellung von Zubereitungen mit antioxidierender
Wirkung zur Verabreichung an Menschen zu Emährungszwecken.</claim-text></claim></claims><claims lang="EN" status="new"><claim num="xx"><claim-text>Use of a compound having general formula (I)

wherein R = H (FPA compound) or R = CH3 (FPB compound)
for the preparation of compositions with an antioxidant
activity for administering to human beings for therapeutic
purposes.</claim-text></claim><claim num="xx"><claim-text>A compound (FPB) having formula (I) wherein R = CH3.</claim-text></claim><claim num="xx"><claim-text>Compositions useful as food integrators containing
as active ingredient a compound having general formula
(I) as defined above wherein R = CH3 (FPB compound).</claim-text></claim><claim num="xx"><claim-text>Pharmaceutical compositions containing as active ingredient
a compound having general formula (I) as defined
above,.</claim-text></claim><claim num="xx"><claim-text>A process for the preparation of a compound having
general formula I as defined above, characterized in that
a cellular culture is obtained from a plant of Ajuga reptans,
said culture being subsequently subjected to cultivation
under aerobic conditions, in a liquid medium containing
assimilable carbon and nitrogen sources, and mineral
salts.</claim-text></claim><claim num="xx"><claim-text>The process according to claim 5, characterized in
that said cultivation under aerobic conditions is carried
out at a pH ranging from 5 to 7, at a temperature ranging
from 18 to 32°C and for a time varying from 8 to 20 days.</claim-text></claim><claim num="xx"><claim-text>Use of a compound having general formula (I)

   wherein R = CH3 (FPB compound)
for the preparation of compositions with an antioxidant
activity for administering to human beings for
nutritional purposes.</claim-text></claim></claims><claims lang="FR" status="new"><claim num="xx"><claim-text>Utilisation d'un composé de formule générale
<claim-text><claim-text>(I) :
</claim-text></claim-text>
   dans laquelle R = H (composé FPA) ou R = CH3
(composé FPB), pour la préparation de compositions ayant
une activité antioxydante destinées à être administrées à
des êtres humains à des fins thérapeutiques.</claim-text></claim><claim num="xx"><claim-text>Composé (FPB) de formule (I), dans laquelle R
= CH3.</claim-text></claim><claim num="xx"><claim-text>Compositions utiles en tant qu'intégrateurs
alimentaires contenant, comme principe actif, un composé
de formule générale (I) telle que définie ci-dessus dans
laquelle R = CH3 (composé FPB).</claim-text></claim><claim num="xx"><claim-text>Compositions pharmaceutiques contenant comme
principe actif un composé de formule générale (I) telle
que définie ci-dessus.</claim-text></claim><claim num="xx"><claim-text>Procédé de préparation d'un composé de formule
générale (I) telle que définie ci-dessus, caractérisé en
ce qu'une culture cellulaire est obtenue d'une plante de
Ajuga reptans, ladite culture étant ensuite soumise à une
cultivation dans des conditions aérobies, dans un milieu
liquide contenant des sources de carbone et d'azote
assimilables, et des sels minéraux.</claim-text></claim><claim num="xx"><claim-text>Procédé selon la revendication 5, caractérisé en
ce que ladite cultivation dans des conditions aérobies
est réalisée à un pH compris dans la plage de 5 à 7, à
une température comprise dans la plage de 18 à 32°C, et
pendant une durée variant de 8 à 20 jours.</claim-text></claim><claim num="xx"><claim-text>Utilisation d'un composé de formule générale
(I) :

   dans laquelle R = CH3 (composé FPB), pour la
préparation de compositions ayant une activité
antioxydante destinées à être administrées à des êtres
humains à des fins nutritionnelles.</claim-text></claim></claims><legal-status status="new"><legal-event country="EP" code="REG" date="20070315"><legal-event-body><event-title>REFERENCE TO A NATIONAL CODE</event-title><event-attributes><event-attribute><event-attribute-label>Ref Country Code </event-attribute-label><event-attribute-value>CH</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Ref Legal Event Code </event-attribute-label><event-attribute-value>PFA</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Owner name </event-attribute-label><event-attribute-value>GIULIANI INTERNATIONAL LIMITED</event-attribute-value></event-attribute><event-attribute><event-attribute-label>free format text </event-attribute-label><event-attribute-value>GIULIANI INTERNATIONAL LIMITED#GRAND CANAL HOUSE 1 UPPER GRAND CANAL STREET#DUBLIN 4 (IE) -TRANSFERTO- GIULIANI INTERNATIONAL LIMITED#33 SIR JOHN ROGERSON'S QUAY#DUBLIN 2 (IE)</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="26N" date="20060719"><legal-event-body><event-title>NO OPPOSITION FILED</event-title><event-attributes><event-attribute><event-attribute-label>Effective Date </event-attribute-label><event-attribute-value>20060511</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="ET" date="20060519"><legal-event-body><event-title>FR: TRANSLATION FILED</event-title></legal-event-body></legal-event><legal-event country="EP" code="NLS" date="20060501"><legal-event-body><event-title>NL: ASSIGNMENTS OF EP-PATENTS</event-title><event-attributes><event-attribute><event-attribute-label>Owner name </event-attribute-label><event-attribute-value>GIULIANI INTERNATIONAL LIMITED</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Effective Date </event-attribute-label><event-attribute-value>20060228</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="REG" date="20060308"><legal-event-body><event-title>REFERENCE TO A NATIONAL CODE</event-title><event-attributes><event-attribute><event-attribute-label>Ref Country Code </event-attribute-label><event-attribute-value>GB</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Ref Legal Event Code </event-attribute-label><event-attribute-value>732E</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="REG" date="20060301"><legal-event-body><event-title>REFERENCE TO A NATIONAL CODE</event-title><event-attributes><event-attribute><event-attribute-label>Ref Country Code </event-attribute-label><event-attribute-value>ES</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Ref Legal Event Code </event-attribute-label><event-attribute-value>FG2A</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Ref Document Number </event-attribute-label><event-attribute-value>2246992</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Kind Code of Ref Document </event-attribute-label><event-attribute-value>T3</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="NLT2" date="20060201"><legal-event-body><event-title>NL: MODIFICATIONS (OF NAMES), TAKEN FROM THE EUROPEAN PATENT PATENT BULLETIN</event-title><event-attributes><event-attribute><event-attribute-label>Owner name </event-attribute-label><event-attribute-value>GIULIANI INTERNATIONAL LIMITED</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Effective Date </event-attribute-label><event-attribute-value>20051207</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="REG" date="20051219"><legal-event-body><event-title>REFERENCE TO A NATIONAL CODE</event-title><event-attributes><event-attribute><event-attribute-label>Ref Country Code </event-attribute-label><event-attribute-value>DK</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Ref Legal Event Code </event-attribute-label><event-attribute-value>T3</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="RAP2" date="20051207"><legal-event-body><event-title>PATENT OWNER REASSIGNMENT (CORRECTION)</event-title><event-attributes><event-attribute><event-attribute-label>Owner name </event-attribute-label><event-attribute-value>GIULIANI INTERNATIONAL LIMITED</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="REG" date="20051130"><legal-event-body><event-title>REFERENCE TO A NATIONAL CODE</event-title><event-attributes><event-attribute><event-attribute-label>Ref Country Code </event-attribute-label><event-attribute-value>CH</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Ref Country Code </event-attribute-label><event-attribute-value>CH</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Ref Legal Event Code </event-attribute-label><event-attribute-value>NV</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Ref Legal Event Code </event-attribute-label><event-attribute-value>PUE</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Owner name </event-attribute-label><event-attribute-value>GIULIANI INTERNATIONAL LIMITED</event-attribute-value></event-attribute><event-attribute><event-attribute-label>free format text </event-attribute-label><event-attribute-value>GIULIANI S.P.A.#VIA PALAGI, 2#I-20129 MILANO (IT) -TRANSFER TO- GIULIANI INTERNATIONAL LIMITED#GRAND CANAL HOUSE 1 UPPER GRAND CANAL STREET#DUBLIN 4 (IE)</event-attribute-value></event-attribute><event-attribute><event-attribute-label>representative=s name </event-attribute-label><event-attribute-value>AMMANN PATENTANWAELTE AG BERN</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="REF" date="20050915"><legal-event-body><event-title>CORRESPONDS TO:</event-title><event-attributes><event-attribute><event-attribute-label>Ref Document Number </event-attribute-label><event-attribute-value>60112482</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Country of Ref Document </event-attribute-label><event-attribute-value>DE</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Date of Ref Document </event-attribute-label><event-attribute-value>20050915</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Kind Code of Ref Document </event-attribute-label><event-attribute-value>P</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="REG" date="20050907"><legal-event-body><event-title>REFERENCE TO A NATIONAL CODE</event-title><event-attributes><event-attribute><event-attribute-label>Ref Country Code </event-attribute-label><event-attribute-value>IE</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Ref Legal Event Code </event-attribute-label><event-attribute-value>FG4D</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="REG" date="20050815"><legal-event-body><event-title>REFERENCE TO A NATIONAL CODE</event-title><event-attributes><event-attribute><event-attribute-label>Ref Country Code </event-attribute-label><event-attribute-value>CH</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Ref Legal Event Code </event-attribute-label><event-attribute-value>EP</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="AK" date="20050810"><legal-event-body><event-title>DESIGNATED CONTRACTING STATES:</event-title><event-attributes><event-attribute><event-attribute-label>Kind Code of Ref Document </event-attribute-label><event-attribute-value>B1</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Designated State(s) </event-attribute-label><event-attribute-value>ATBECHCYDEDKESFIFRGBGRIEITLILUMCNLPTSETR</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="REG" date="20050810"><legal-event-body><event-title>REFERENCE TO A NATIONAL CODE</event-title><event-attributes><event-attribute><event-attribute-label>Ref Country Code </event-attribute-label><event-attribute-value>GB</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Ref Legal Event Code </event-attribute-label><event-attribute-value>FG4D</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="RIN1" date="20050810"><legal-event-body><event-title>INVENTOR (CORRECTION)</event-title><event-attributes><event-attribute><event-attribute-label>inventor name </event-attribute-label><event-attribute-value>CRESPI PERELLINO , NICOLETTA</event-attribute-value></event-attribute><event-attribute><event-attribute-label>inventor name </event-attribute-label><event-attribute-value>DANIELI , BRUNO</event-attribute-value></event-attribute><event-attribute><event-attribute-label>inventor name </event-attribute-label><event-attribute-value>FRIGERIO , GIULIANO</event-attribute-value></event-attribute><event-attribute><event-attribute-label>inventor name </event-attribute-label><event-attribute-value>MARCHIORETTO , DANILA INGRID</event-attribute-value></event-attribute><event-attribute><event-attribute-label>inventor name </event-attribute-label><event-attribute-value>MINGHETTI , ANACLETO</event-attribute-value></event-attribute><event-attribute><event-attribute-label>inventor name </event-attribute-label><event-attribute-value>RODA , ALDO</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="17Q" date="20031029"><legal-event-body><event-title>FIRST EXAMINATION REPORT</event-title><event-attributes><event-attribute><event-attribute-label>Effective Date </event-attribute-label><event-attribute-value>20030911</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="AKX" date="20020417"><legal-event-body><event-title>PAYMENT OF DESIGNATION FEES</event-title><event-attributes><event-attribute><event-attribute-label>free format text </event-attribute-label><event-attribute-value>AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="17P" date="20020102"><legal-event-body><event-title>REQUEST FOR EXAMINATION FILED</event-title><event-attributes><event-attribute><event-attribute-label>Effective Date </event-attribute-label><event-attribute-value>20011029</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="AK" date="20010725"><legal-event-body><event-title>DESIGNATED CONTRACTING STATES:</event-title><event-attributes><event-attribute><event-attribute-label>Kind Code of Ref Document </event-attribute-label><event-attribute-value>A1</event-attribute-value></event-attribute><event-attribute><event-attribute-label>Designated State(s) </event-attribute-label><event-attribute-value>ATBECHCYDEDKESFIFRGBGRIEITLILUMCNLPTSETR</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event><legal-event country="EP" code="AX" date="20010725"><legal-event-body><event-title>EXTENSION OF THE EUROPEAN PATENT TO</event-title><event-attributes><event-attribute><event-attribute-label>free format text </event-attribute-label><event-attribute-value>AL;LT;LV;MK;RO;SI</event-attribute-value></event-attribute></event-attributes></legal-event-body></legal-event></legal-status></patent-document>